Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.
Company profile
Website
CEO
Brenton L. Saunders
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
951622442
Latest filings (excl ownership)
15-15D
Suspension of duty to report
17 Apr 15
15-15D
Suspension of duty to report
17 Apr 15
15-15D
Suspension of duty to report
17 Apr 15
15-12B
Securities registration termination
27 Mar 15
8-K
Completion of Acquisition or Disposition of Assets
18 Mar 15
25-NSE
Exchange delisting
17 Mar 15
POSASR
Automatic shelf registration (post-effective amendment)
17 Mar 15
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Mar 15
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Mar 15
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Mar 15
Latest ownership filings
Institutional ownership, Q3 2022
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|